Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony H Schapira

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2011
Etiology and pathogenesis of Parkinson's diseaseAnthony H Schapira, Peter Jenner
Movement Disorders : Official Journal of the Movement Disorder Society|May 16, 2013
Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary dataChristos Proukakis, Henry Houlden, Anthony H Schapira
Journal of Parkinson'S Disease|June 10, 2017
Glucocerebrosidase Mutations in Parkinson DiseaseGrace O'Regan, Ruth-Mary deSouza, Roberta Balestrino, et al.
Lancet (London, England)|August 18, 2009
Drug-induced fibrotic valvular heart diseaseSanjeev Bhattacharyya, Anthony H Schapira, Dimitri P Mikhailidis, et al.
Journal of Cell Science|September 1, 2016
Endo-lysosomal TRP mucolipin-1 channels trigger global ER Ca2+ release and Ca2+ influxBethan S Kilpatrick, Elizabeth Yates, Christian Grimm, et al.
Journal of Neurochemistry|February 9, 2006
Pramipexole protects against MPTP toxicity in non-human primatesMahmoud M Iravani, Claire O Haddon, J Mark Cooper, et al.
Frontiers in Neurology|November 16, 2020
Investigation of Somatic Mutations in Human Brains Targeting Genes Associated With Parkinson's DiseaseMelissa Leija-Salazar, Alan Pittman, Katya Mokretar, et al.
Journal of Cell Science|October 31, 2012
Direct mobilisation of lysosomal Ca2+ triggers complex Ca2+ signalsBethan S Kilpatrick, Emily R Eden, Anthony H Schapira, et al.
Journal of Cell Science|February 19, 2021
The lysosomotrope GPN mobilises Ca<sup>2+</sup> from acidic organellesYu Yuan, Bethan S Kilpatrick, Susanne Gerndt, et al.
Journal of Parkinson'S Disease|April 21, 2026
Rethinking our strategies to develop disease-modifying therapies for Parkinson's: Time for combination therapies?Paloma Fernandez, Rachel M Hughes, Helen Matthews, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2011
Etiology and pathogenesis of Parkinson's diseaseAnthony H Schapira, Peter Jenner
Movement Disorders : Official Journal of the Movement Disorder Society|May 16, 2013
Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary dataChristos Proukakis, Henry Houlden, Anthony H Schapira
Journal of Parkinson'S Disease|June 10, 2017
Glucocerebrosidase Mutations in Parkinson DiseaseGrace O'Regan, Ruth-Mary deSouza, Roberta Balestrino, et al.
Lancet (London, England)|August 18, 2009
Drug-induced fibrotic valvular heart diseaseSanjeev Bhattacharyya, Anthony H Schapira, Dimitri P Mikhailidis, et al.
Journal of Cell Science|September 1, 2016
Endo-lysosomal TRP mucolipin-1 channels trigger global ER Ca2+ release and Ca2+ influxBethan S Kilpatrick, Elizabeth Yates, Christian Grimm, et al.
Journal of Neurochemistry|February 9, 2006
Pramipexole protects against MPTP toxicity in non-human primatesMahmoud M Iravani, Claire O Haddon, J Mark Cooper, et al.
Frontiers in Neurology|November 16, 2020
Investigation of Somatic Mutations in Human Brains Targeting Genes Associated With Parkinson's DiseaseMelissa Leija-Salazar, Alan Pittman, Katya Mokretar, et al.
Journal of Cell Science|October 31, 2012
Direct mobilisation of lysosomal Ca2+ triggers complex Ca2+ signalsBethan S Kilpatrick, Emily R Eden, Anthony H Schapira, et al.
Journal of Cell Science|February 19, 2021
The lysosomotrope GPN mobilises Ca<sup>2+</sup> from acidic organellesYu Yuan, Bethan S Kilpatrick, Susanne Gerndt, et al.
Journal of Parkinson'S Disease|April 21, 2026
Rethinking our strategies to develop disease-modifying therapies for Parkinson's: Time for combination therapies?Paloma Fernandez, Rachel M Hughes, Helen Matthews, et al.
Pageof 4